Editorial

You have full text access to this OnlineOpen article

Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?†‡

  1. Mary E. Rinella M.D.§,*

Article first published online: 27 SEP 2011

DOI: 10.1002/hep.24634

Issue

Hepatology

Hepatology

Volume 54, Issue 4, pages 1118–1120, October 2011

Additional Information

How to Cite

Rinella, M. E. (2011), Will the increased prevalence of nonalcoholic steatohepatitis (NASH) in the age of better hepatitis C virus therapy make NASH the deadlier disease?. Hepatology, 54: 1118–1120. doi: 10.1002/hep.24634

Author Information

  1. Department of Medicine Northwestern University Feinberg School of Medicine Chicago, IL

  1. §

    fax: 312-908-6192

*Department of Medicine, Northwestern University Feinberg School of Medicine, 303 East Chicago Avenue, Searle 10-563, Chicago, IL 60611

  1. †

    See Article on Page 1208

  2. ‡

    Potential conflict of interest: Nothing to report.

  3. §

    fax: 312-908-6192

Publication History

  1. Issue published online: 27 SEP 2011
  2. Article first published online: 27 SEP 2011
  3. Accepted manuscript online: 30 AUG 2011 08:45AM EST
  4. Manuscript Accepted: 23 AUG 2011

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (57K)

No abstract is available for this article.

View Full Article (HTML) Get PDF (57K)